Harrow’s Strong VEVYE and IHEEZO Momentum Supports Buy Rating; $70 Price Target Unchanged
at www.tipranks.com (Wed, 11-Nov 7:36 AM)
at www.tipranks.com (Wed, 11-Nov 5:26 AM)
Harrow stock jumps as eye-care products deliver record Q3 sales
at seekingalpha.com (Tue, 10-Nov 11:22 AM)
Analysts’ Top Healthcare Picks: Ascendis Pharma (ASND), Harrow Health (HROW)
at www.tipranks.com (Tue, 10-Nov 10:40 AM)
Harrow Health Reports Record Third-Quarter Revenue and Earnings
at www.tipranks.com (Mon, 9-Nov 5:11 PM)
Harrow Health GAAP EPS of $0.25 beats by $0.06, revenue of $99.3M beats by $0.71M
at seekingalpha.com (Mon, 9-Nov 4:23 PM)
